CSPC Pharmaceutical Group Limited. Net Tangible Assets

CSPC Pharmaceutical Group Limited. (CSPCY) currently reports a net tangible assets of $39B as of June 2026. That compares with $35B in the prior-year period — up 13.1% year over year. Use the charts on this page to explore CSPC Pharmaceutical Group Limited.'s net tangible assets history and peer comparisons.

CSPC Pharmaceutical Group Limited.'s net tangible assets increased from $35B to $39B — a 13.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CSPC Pharmaceutical Group Limited. reported $39B in net tangible assets as of June 2026. That compares with $35B in the prior-year period — up 13.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $39B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CSPC Pharmaceutical Group Limited., and consider following CSPCY for alerts when major investors trade the stock.

CSPC Pharmaceutical Group Limited. is classified in the Healthcare sector. On net tangible assets, it currently shows $39B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSPCY with unrelated industries.